Skip to main content
. 2018 Aug 20;7:212539. doi: 10.7573/dic.212539

Figure 3.

Figure 3

Mean percentage reduction in baseline PASI and SAPASI scores following treatment of psoriatic lesions with BMVP 0.1% or BMV cream 0.12%.29.

*p<0.01 versus BMV cream.

BMV, betamethasone valerate; BMVP, betamethasone valerate medicated plaster; PASI, psoriasis area and severity index; SAPSI, self-administered PASI.